Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000872036 | SCV001013786 | benign | Cataract 20 multiple types | 2022-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027802 | SCV004851650 | uncertain significance | Inborn genetic diseases | 2023-10-03 | criteria provided, single submitter | clinical testing | The c.39C>A (p.D13E) alteration is located in exon 2 (coding exon 2) of the CRYGS gene. This alteration results from a C to A substitution at nucleotide position 39, causing the aspartic acid (D) at amino acid position 13 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004716620 | SCV005305179 | benign | not provided | criteria provided, single submitter | not provided |